Old Web
English
Sign In
Acemap
>
authorDetail
>
Nathan D. Seligson
Nathan D. Seligson
University of Florida
Medicine
Cancer
Precision medicine
Internal medicine
Clinical trial
9
Papers
44
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic target.
2021
Nathan D. Seligson
Richard D Maradiaga
Colin M Stets
Howard M. Katzenstein
Sherri Z. Millis
Alan Rogers
John L. Hays
James L. Chen
Show All
Source
Cite
Save
Citations (0)
Adding the second T: Elevating STAR to START for behavioral interviewing.
2020
American Journal of Health-system Pharmacy
Jon M Apple
Jack C Guerci
Nathan D. Seligson
Stacey D. Curtis
Show All
Source
Cite
Save
Citations (0)
Sacituzumab Govitecan-hziy: An Antibody-Drug Conjugate for the Treatment of Refractory, Metastatic, Triple-Negative Breast Cancer.
2020
Annals of Pharmacotherapy
John M Seligson
Alexandra M Patron
Michael Berger
R. Donald Harvey
Nathan D. Seligson
Show All
Source
Cite
Save
Citations (11)
Recommendations for patient similarity classes: results of the AMIA 2019 workshop on defining patient similarity.
2020
Journal of the American Medical Informatics Association
Nathan D. Seligson
Jeremy L. Warner
William S. Dalton
David Martin
Robert S. Miller
Debra A. Patt
Kenneth L. Kehl
Matvey B. Palchuk
Gil Alterovitz
Laura K Wiley
Ming Huang
Feichen Shen
Yanshan Wang
Khoa A Nguyen
Anthony F Wong
Funda Meric-Bernstam
Elmer V. Bernstam
James L. Chen
Show All
Source
Cite
Save
Citations (6)
1